Overview
Legal name
AGPLUS DIAGNOSTICS LTD
Region
London
Registered address
66 LINCOLN'S INN FIELDS
LONDON
WC2A 3LH
Insolvency history
No
Company
Active
LTD
Company profile
Agplus Diagnostics Ltd
Home | AgPlus Diagnostics
AgPlus Diagnostics offer point of care testing solutions, test development services & manufacturing to businesses across the USA and Europe.
CRN
06994240
Founded
2009
Age
16
Corporate ownership
Updated 06 Jun 2026 16:52
1 level
1 ultimate controller
1
Company
Active
LTD
Agplus Diagnostics Ltd
CRN 06994240
2
Direct and ultimate controller
Active
LTD
Agplus Holdings Limited
CRN 09600243
Latest accounts
Financial period: 1 Jan 2024 to 31 Dec 2024
FILLETEDACCOUNTS
Turnover
Unknown
Profit / Loss
Unknown
Employees
1
Company events
Reference milestones and recent Companies House filing stream events.
6 events
30 Sep
2026
Accounts due
Accounts DueNext accounts due date
16 Aug
2026
Confirmation statement due
Confirmation DueNext confirmation statement due date
02 Aug
2025
Confirmation statement filed
ConfirmationLast confirmation statement made up date
31 Dec
2024
Accounts filed
AccountsLast accounts made up date
08 Aug
2024
Accounts With Accounts Type Total Exemption Full
Accounts AnalysedAA | Transaction MzQzMTYzNjQ4MmFkaXF6a2N4
Published 08 Aug 2024 15:32
19 Aug
2009
Incorporated
InceptionCompany registered at Companies House
Public funding
3 awards
First funded
2017
Funded years
2017, 2020
Age at first award
7 years
Projects
2020
Collaborative R&D
Lead participant
Development of AgPlus rapid electrochemical immunoassays for COVID-19
1 Sep 2020 to 28 Feb 2021
Awarded
£174,845
Total cost £174,845
SARS-CoV-2 or COVID-19 is virus that is currently spreading throughout the world. Relatively little is understood about the virus but we are learning fast and it is clear that we need to have good diagnosis to support quarantine and treatment. What is known is that the virus has a serial interval of 4 days and 1-3% of the population may be pre-symptomatic...
2020
Feasibility Studies
Lead participant
AgPlus Electrochemical COVID-19 Diagnostic Assay
1 Jul 2020 to 31 Dec 2020
Awarded
£49,498
Total cost £49,498
SARS-CoV-2 or COVID-19 is currently spreading throughout the world. Little is understood about the virus but we are learning fast and it is clear that we need to have good, accurate diagnosis to support quarantine and treatment. What is known is that the virus has a serial interval of 4 days and 1-3% of the population may be pre-symptomatic but still tran...
2017
Collaborative R&D
Lead participant
Quality Control Test for a Carbon Electrode in a Point-of-Care Diagnostic Test Cartridge
1 Jun 2017 to 31 Mar 2018
Awarded
£44,006
Total cost £62,865
AgPlus Diagnostics produces medical test devices that can be used by a doctor to give patients information on their health in less than 10 minutes during a single doctor’s appointment. Our medical device is used by inserting a test cartridge into a handheld reader that performs the medical test using AgPlus’s unique signal detection chemistry. This is cal...
Product types
Collaborative R&D
Feasibility Studies